IP Library Granted Patent US 12,290,785
Granted Patent B2
US 12,290,785 · App. 18/082,152 · Granted May 6, 2025

Tangential flow filter system for the filtration of materials from biologic fluids

Inventors: Emily Rolfes Meyering (St. Louis Park, MN); Gary Seim (Minneapolis, MN); Abhi Vase (Los Altos Hills, CA); Ben Krehbiel (Lake City, MN); Blake Hedstrom (Minneapolis, MN); Aaron McCabe (Edina, MN); Jack Mondry (Edina, MN)
B01D61/58A61M1/88A61M1/884A61M25/00B01D61/145B01D61/147B01D61/149B01D61/32A61M27/006A61M2202/0464A61M2205/3327A61M2205/3334A61M2205/75A61M2206/11A61M2230/005B01D2311/12B01D2311/16B01D2313/12B01D2313/18B01D2315/08B01D2315/10B01D2317/022B01D2317/04B01D2317/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,785
App. No.
18/082,152
Granted
May 6, 2025
Kind
B2
Abstract

Systems and methods for filtering materials from biologic fluids are discussed. Embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject. In an example, CSF is separated into a permeate and retentate using a tangential flow filter. The retentate is filtered again and then returned to the subject with the permeate. During operation of the system, various parameters may be modified, such as flow rate and waste rate.

Claims (27)

1. A system for removing materials from cerebrospinal fluid (CSF) of a human or animal fluid (CSF) of a human or animal subject, the system comprising:

a filtration subsystem configured to withdraw a volume of cerebrospinal fluid from the human or animal subject, filter the withdrawn volume of cerebrospinal fluid into a volume of permeate and a volume of retentate, filter the volume of retentate into a second volume of permeate and a second volume of retentate, return the volume of permeate and the second volume of permeate to the human or animal subject, and direct the second volume of retentate to a waste container; and

a plurality of sensors, cooperating with a processor located and configured to generate and receive data, including during filtration of the fluid through the filtration subsystem, indicating the volume of cerebrospinal fluid withdrawn from the human or animal subject, generate and receive data indicating the volume of permeate returned to the human or animal subject, generate and receive data indicating the flow volume of second permeate returned to the human or animal subject, and calculate a waste rate of the system, wherein the waste rate is the difference between the volume of fluid withdrawn from the subject and the flow volume of returned permeate returned to the subject combined with the returned volume of second permeate returned to the subject over a period of time.

2. The system of claim 1 , wherein the processor is further configured to modify one or more parameters of the filtration system that influence the waste rate to maintain the waste rate less than a threshold waste rate.

3. The system of claim 2 , wherein the one or more parameters of the system include one or more of: a rate of withdrawal of cerebrospinal fluid from the subject; a rate of return of permeate to the subject; and a rate of addition of artificial cerebrospinal fluid to the volume of permeate returned to the subject.

4. The system of claim 2 , wherein the threshold waste rate is 0.25 milliliters per minute or less.

5. The system of claim 1 , wherein the processor is configured to maintain the waste rate within a predetermined threshold range.

6. The system of claim 5 , wherein the processor is configured such that when the calculated waste rate is above the predetermined threshold range, the processor modifies one or more parameters of the system that influence the waste rate to bring the waste rate down into the predetermined threshold range.

7. The system of claim 6 , wherein the processor is configured such that when the calculated waste rate is below the predetermined threshold range, the processor modifies one or more parameters of the system that influence the waste rate to bring the waste rate up into the predetermined threshold range.

8. The system of claim 7 , wherein the predetermined threshold range is between 0.2 milliliters per minute and 0.25 milliliters per minute.

9. The system of claim 1 , wherein the filtration subsystem includes a first tangential flow filter for generating the volume of permeate and the volume of retentate and a second tangential flow filter for generating the second volume of permeate and the second volume of retentate.

10. The system of claim 1 , wherein the filtration subsystem includes a pump configured to cause the volume of cerebrospinal fluid to be withdrawn the from the subject, cause the withdrawn volume of cerebrospinal fluid to be transferred to one or more filters along a first fluid pathway of the system, and to cause the volume of permeate to be returned to the human or animal subject along a second fluid pathway of the system.

11. A system for removing materials from cerebrospinal fluid (CSF) of a human or animal subject, the system including:

a first fluid pathway;

a filtration subsystem in fluid communication with the first fluid pathway, the filtration subsystem configured to filter cerebrospinal fluid;

a permeate outlet fluid pathway in fluid communication with the filtration subsystem;

a retentate outlet fluid pathway in fluid communication with the filtration subsystem;

a pump configured to cause a volume of cerebrospinal fluid to be withdrawn from the human or animal subject and transferred along the first fluid pathway to the filtration subsystem for filtration into a permeate volume and a retentate volume, the pump and filtration subsystem further configured to cause the retentate volume to be transferred to the filtration subsystem for filtration into a second permeate volume and a second retentate volume, the pump further configured to cause the permeate volume and the second permeate volume to be transferred along the permeate outlet fluid pathway and to be returned to the human or animal subject, and to cause the second retentate volume to be transferred along the retentate outlet fluid pathway to a waste container; and

a plurality of sensors, cooperating with a processor configured to generate and receive data, including during filtration of the fluid through the filtration subsystem, indicating the volume of cerebrospinal fluid withdrawn from the human or animal subject, generate and receive data indicating the volume of permeate returned to the human or animal subject, generate and receive data indicating the flow volume of second permeate returned to the human or animal subject, and calculate a waste rate of the system, wherein the waste rate is the difference between the volume of fluid withdrawn from the subject and the flow volume of returned permeate returned to the subject combined with the returned flow volume of second permeate returned to the subject over a period of time.

12. The system of claim 11 , wherein the processor is further configured to modify one or more operating parameters of the pump that influence the waste rate to maintain the waste rate less than a threshold waste rate.

13. The system of claim 12 , wherein the one or more parameters of the system include one or more of: a rate of withdrawal of cerebrospinal fluid from the subject; a rate of return of permeate to the subject; and a rate of addition of artificial cerebrospinal to the volume of permeate returned to the subject.

14. The system of claim 12 , wherein the threshold waste rate is 0.25 milliliters per minute or less.

15. The system of claim 12 , wherein the processor is configured to maintain the waste rate within a predetermined threshold range.

16. The system of claim 15 , wherein the processor is configured such that when the calculated waste rate is above the predetermined threshold range, the processor modifies one or more parameters of the system that influence the waste rate to bring the waste rate down into the predetermined threshold range.

17. The system of claim 16 , wherein the processor is configured such that when the calculated waste rate is below the predetermined threshold range, the processor modifies one or more parameters of the system that influence the waste rate to bring the waste rate up into the predetermined threshold range.

18. The system of claim 17 , wherein the predetermined threshold range is between 0.2 milliliters per minute and 0.25 milliliters per minute.

19. The system of claim 11 , wherein the filtration subsystem includes a first tangential flow filter for generating the volume of permeate and the volume of retentate and a second tangential flow filter for generating the second volume of permeate and the second volume of retentate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2025
From: MINNETRONIX NEURO, INC.
To: PHARAOH NEURO, INC.
Reel/Frame 073429/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: MINNETRONIX, INC.
To: MINNETRONIX NEURO, INC.
Reel/Frame 071588/0980 →
ASSIGNMENT OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED ON REEL 054795 FRAME 0607 AND SUPPLEMENTAL PATENT SECURITY AGREEMENT RECORDED ON REEL 056240 FRAME 0147 Recorded Mar 13, 2025
From: FIRST HORIZON BANK
To: TEXAS CAPITAL BANK, AS SUCCESSOR AGENT
Reel/Frame 073460/0969 →
Continuity (4)
Continuation 16851575 · Apr 17, 2020
Division 15229392 · Aug 5, 2016
Provisional Application 62201287 · Aug 5, 2015
Related Publication 20230120296A1 · Apr 20, 2023
References Cited (400)
US 2969066A · Holter et al. · 1961 [cited by applicant]
US 3419010A · Williamson · 1968 [cited by applicant]
US 3867937A · Schwartz · 1975 [cited by applicant]
US 3889687A · Harris et al. · 1975 [cited by applicant]
US 4378797A · Osterholm · 1983 [cited by applicant]
US 4446154A · Osterholm · 1984 [cited by applicant]
US 4451251A · Osterholm · 1984 [cited by applicant]
US 4551137A · Osborne · 1985 [cited by applicant]
US 4686085A · Osterholm · 1987 [cited by applicant]
US 4695541A · Taylor · 1987 [cited by applicant]
US 4767409A · Brooks · 1988 [cited by applicant]
US 4830849A · Osterholm · 1989 [cited by applicant]
US 4888115A · Marinaccio et al. · 1989 [cited by applicant]
US 4904237A · Janese · 1990 [cited by applicant]
US 4950232A · Ruzicka et al. · 1990 [cited by applicant]
US 4958901A · Coombs · 1990 [cited by applicant]
US 5143630A · Rolchigo · 1992 [cited by examiner]
US 5160323A · Andrew · 1992 [cited by applicant]
US 5171226A · McCrory · 1992 [cited by applicant]
US 5190529A · McCrory et al. · 1993 [cited by applicant]
US 5334315A · Matkovitch et al. · 1994 [cited by applicant]
US 5396899A · Strittmatter · 1995 [cited by applicant]
US 5405316A · Magram · 1995 [cited by applicant]
US 5423738A · Robinson et al. · 1995 [cited by applicant]
US 5456843A · Koenhen · 1995 [cited by applicant]
US 5462667A · Wollinsky et al. · 1995 [cited by applicant]
US 5531673A · Helenowski · 1996 [cited by applicant]
US 5560828A · Wenten et al. · 1996 [cited by applicant]
US 5601727A · Bormann et al. · 1997 [cited by applicant]
US 5683357A · Magram · 1997 [cited by applicant]
US 5726026A · Wilding et al. · 1998 [cited by applicant]
US 5755968A · Stone · 1998 [cited by applicant]
US 5772607A · Magram · 1998 [cited by applicant]
US 5836928A · Gerber et al. · 1998 [cited by applicant]
US 5897528A · Schultz · 1999 [cited by applicant]
US 5941853A · Collins · 1999 [cited by applicant]
US 5947689A · Schick · 1999 [cited by applicant]
US 5948441A · Lenk et al. · 1999 [cited by applicant]
US 5980480A · Rubenstein et al. · 1999 [cited by applicant]
US 6013051A · Nelson · 2000 [cited by applicant]
US 6022742A · Kopf · 2000 [cited by applicant]
US 6056725A · Elsberry · 2000 [cited by applicant]
US 6113797A · Al-Samadi · 2000 [cited by applicant]
US 6217552B1 · Barbut et al. · 2001 [cited by applicant]
US 6238382B1 · Schock et al. · 2001 [cited by applicant]
US 6264625B1 · Rubenstein et al. · 2001 [cited by applicant]
US 6326044B1 · Lindquist · 2001 [cited by applicant]
US 6350382B1 · Schick · 2002 [cited by applicant]
US 6379331B2 · Barbut et al. · 2002 [cited by applicant]
US 6383159B1 · Saul et al. · 2002 [cited by applicant]
US 6383380B1 · Kopf · 2002 [cited by applicant]
US 6387290B1 · Brody et al. · 2002 [cited by applicant]
US 6468219B1 · Njemanze · 2002 [cited by applicant]
US 6537241B1 · Odland · 2003 [cited by applicant]
US 6558353B2 · Zohmann · 2003 [cited by applicant]
US 6575928B2 · Saul et al. · 2003 [cited by applicant]
US 6594880B2 · Elsberry · 2003 [cited by applicant]
US 6641563B1 · Vitullo et al. · 2003 [cited by applicant]
US 6682508B1 · Meythaler et al. · 2004 [cited by applicant]
US 6689085B1 · Rubenstein et al. · 2004 [cited by applicant]
US 6689756B2 · Hesson et al. · 2004 [cited by applicant]
US 6699269B2 · Khanna · 2004 [cited by applicant]
US 6709426B2 · Gijsbers et al. · 2004 [cited by applicant]
US 6733675B2 · Ando et al. · 2004 [cited by applicant]
US 6758832B2 · Barbut et al. · 2004 [cited by applicant]
US 6830561B2 · Jansen et al. · 2004 [cited by applicant]
US 6849185B1 · Wu et al. · 2005 [cited by applicant]
US 6875192B1 · Saul et al. · 2005 [cited by applicant]
US 6969383B2 · Hildebrand · 2005 [cited by applicant]
US 7011647B2 · Purdy et al. · 2006 [cited by applicant]
US 7025742B2 · Rubenstein et al. · 2006 [cited by applicant]
US 7108680B2 · Rohr et al. · 2006 [cited by applicant]
US 7118549B2 · Chan · 2006 [cited by applicant]
US 7150737B2 · Purdy et al. · 2006 [cited by applicant]
US 7181289B2 · Pflueger et al. · 2007 [cited by applicant]
US 7189221B2 · Silverberg et al. · 2007 [cited by applicant]
US 7214211B2 · Woehr et al. · 2007 [cited by applicant]
US 7252659B2 · Shehada et al. · 2007 [cited by applicant]
US 7318834B2 · Njemanze · 2008 [cited by applicant]
US 7455666B2 · Purdy · 2008 [cited by applicant]
US 7708716B2 · Shah · 2010 [cited by applicant]
US 7787954B2 · Purdy · 2010 [cited by applicant]
US 7842002B2 · Mantle · 2010 [cited by applicant]
US 7850723B1 · Magers · 2010 [cited by applicant]
US 7887503B2 · Geiger · 2011 [cited by applicant]
US 8029495B2 · Pyles · 2011 [cited by applicant]
US 8131353B2 · Purdy · 2012 [cited by applicant]
US 8137334B2 · Heruth et al. · 2012 [cited by applicant]
US 8231586B2 · Kizer et al. · 2012 [cited by applicant]
US 8357296B2 · Bonhomme et al. · 2013 [cited by applicant]
US 8398581B2 · Panotopoulos · 2013 [cited by applicant]
US 8435204B2 · Lad et al. · 2013 [cited by applicant]
US 8444661B2 · Nair et al. · 2013 [cited by applicant]
US 8475419B2 · Eckermann · 2013 [cited by applicant]
US 8486023B2 · Pyles · 2013 [cited by applicant]
US 8486104B2 · Samson et al. · 2013 [cited by applicant]
US 8512280B2 · Rozenberg et al. · 2013 [cited by applicant]
US 8518636B2 · Bosch et al. · 2013 [cited by applicant]
US 8523930B2 · Saunders et al. · 2013 [cited by applicant]
US 8603057B2 · Hoffman et al. · 2013 [cited by applicant]
US 8669044B2 · Chiu et al. · 2014 [cited by applicant]
US 8679751B2 · Huang · 2014 [cited by applicant]
US 8721642B1 · Sullivan · 2014 [cited by applicant]
US 8905968B2 · Thomas · 2014 [cited by applicant]
US 9205184B2 · Eckermann · 2015 [cited by applicant]
US 9211163B1 · Jaramaz et al. · 2015 [cited by applicant]
US 9387311B1 · Heilman et al. · 2016 [cited by applicant]
US 9770180B2 · Radojicic · 2017 [cited by applicant]
US 9895518B2 · Lad et al. · 2018 [cited by applicant]
US 10272188B1 · Geiger · 2019 [cited by applicant]
US 10569064B2 · Vase et al. · 2020 [cited by applicant]
US 10632237B2 · Meyering · 2020 [cited by examiner]
US 10695545B2 · Hedstrom et al. · 2020 [cited by applicant]
US 10850235B2 · Meyering et al. · 2020 [cited by applicant]
US 11529452B2 · Meyering · 2022 [cited by examiner]
US 11577060B2 · Hedstrom · 2023 [cited by examiner]
US 20020043487A1 · Schick · 2002 [cited by applicant]
US 20020077682A1 · Lee et al. · 2002 [cited by applicant]
US 20020123714A1 · Saul et al. · 2002 [cited by applicant]
US 20020156482A1 · Scribner et al. · 2002 [cited by applicant]
US 20020193285A1 · Hesson et al. · 2002 [cited by applicant]
US 20020198579A1 · Khanna · 2002 [cited by applicant]
US 20030004495A1 · Saul · 2003 [cited by applicant]
US 20030014016A1 · Purdy · 2003 [cited by applicant]
US 20030028137A1 · Levin · 2003 [cited by applicant]
US 20030032915A1 · Saul · 2003 [cited by applicant]
US 20030065309A1 · Barnitz · 2003 [cited by applicant]
US 20030072761A1 · LeBowitz · 2003 [cited by applicant]
US 20030083698A1 · Whitehurst et al. · 2003 [cited by applicant]
US 20030097082A1 · Purdy et al. · 2003 [cited by applicant]
US 20030129134A1 · Chenard et al. · 2003 [cited by applicant]
US 20030130577A1 · Purdy et al. · 2003 [cited by applicant]
US 20030130651A1 · Lennox · 2003 [cited by applicant]
US 20030135196A1 · Hesson et al. · 2003 [cited by applicant]
US 20030163181A1 · Frazer et al. · 2003 [cited by applicant]
US 20030199802A1 · Barbut · 2003 [cited by applicant]
US 20040015133A1 · Karim · 2004 [cited by applicant]
US 20040030279A1 · Rubenstein et al. · 2004 [cited by applicant]
US 20040068221A1 · Silverberg et al. · 2004 [cited by applicant]
US 20040138125A1 · Wang · 2004 [cited by applicant]
US 20040138728A1 · Wong et al. · 2004 [cited by applicant]
US 20040142906A1 · Wang · 2004 [cited by applicant]
US 20040147987A1 · Ginsburg et al. · 2004 [cited by applicant]
US 20040210231A1 · Boucher et al. · 2004 [cited by applicant]
US 20040215162A1 · Putz · 2004 [cited by applicant]
US 20040220545A1 · Heruth et al. · 2004 [cited by applicant]
US 20050004504A1 · Frye et al. · 2005 [cited by applicant]
US 20050060006A1 · Pflueger et al. · 2005 [cited by applicant]
US 20050090801A1 · Racz et al. · 2005 [cited by applicant]
US 20050126961A1 · Bissler et al. · 2005 [cited by applicant]
US 20060015160A1 · Lamard · 2006 [cited by applicant]
US 20060016751A1 · Ali et al. · 2006 [cited by applicant]
US 20060030027A1 · Ellson et al. · 2006 [cited by applicant]
US 20060045796A1 · Anderle et al. · 2006 [cited by applicant]
US 20060058836A1 · Bose et al. · 2006 [cited by applicant]
US 20060142783A1 · Lewis et al. · 2006 [cited by applicant]
US 20060175543A1 · Elefteriades · 2006 [cited by applicant]
US 20060184098A1 · Barnitz et al. · 2006 [cited by applicant]
US 20060224101A1 · Glenn · 2006 [cited by applicant]
US 20060254984A1 · Polyakov · 2006 [cited by applicant]
US 20060282043A1 · Pyles · 2006 [cited by applicant]
US 20070050002A1 · Elefteriades · 2007 [cited by applicant]
US 20070246406A1 · Dibel et al. · 2007 [cited by applicant]
US 20080045883A1 · Radojicic · 2008 [cited by applicant]
US 20080154181A1 · Khanna · 2008 [cited by applicant]
US 20080171990A1 · Zauner · 2008 [cited by applicant]
US 20080176271A1 · Silver · 2008 [cited by examiner]
US 20080190848A1 · Oklejas · 2008 [cited by applicant]
US 20080249458A1 · Yamasaki · 2008 [cited by applicant]
US 20080249501A1 · Yamasaki · 2008 [cited by applicant]
US 20080319376A1 · Wilcox et al. · 2008 [cited by applicant]
US 20090000890A1 · Furuya · 2009 [cited by applicant]
US 20090076357A1 · Purdy · 2009 [cited by applicant]
US 20090082800A1 · Janardhan · 2009 [cited by applicant]
US 20090171369A1 · Gayzik · 2009 [cited by applicant]
US 20090277850A1 · Adams et al. · 2009 [cited by applicant]
US 20100030196A1 · Hildebrand et al. · 2010 [cited by applicant]
US 20100145267A1 · Bishop et al. · 2010 [cited by applicant]
US 20100168665A1 · Skerven · 2010 [cited by applicant]
US 20100179509A1 · Pyles · 2010 [cited by applicant]
US 20100181235A1 · Fava · 2010 [cited by examiner]
US 20100198195A1 · Nishtala et al. · 2010 [cited by applicant]
US 20100204672A1 · Lockhart et al. · 2010 [cited by applicant]
US 20100260815A1 · Kyle et al. · 2010 [cited by applicant]
US 20100280438A1 · Thomas · 2010 [cited by applicant]
US 20100305492A1 · Lad et al. · 2010 [cited by applicant]
US 20100324397A1 · Purdy · 2010 [cited by applicant]
US 20110029050A1 · Elefteriades et al. · 2011 [cited by applicant]
US 20110046547A1 · Mantle · 2011 [cited by applicant]
US 20110098623A1 · Zhang et al. · 2011 [cited by applicant]
US 20110190831A1 · Mafi et al. · 2011 [cited by applicant]
US 20110319824A1 · Pyles · 2011 [cited by applicant]
US 20120004625A1 · Velez-Rivera · 2012 [cited by applicant]
US 20120149021A1 · Yung et al. · 2012 [cited by applicant]
US 20120165757A1 · Purdy · 2012 [cited by applicant]
US 20120203142A1 · Bedell · 2012 [cited by applicant]
US 20120203290A1 · Warren et al. · 2012 [cited by applicant]
US 20120209367A1 · Prindle et al. · 2012 [cited by applicant]
US 20120232458A1 · Herschman · 2012 [cited by applicant]
US 20120234694A1 · Vecitis et al. · 2012 [cited by applicant]
US 20120253266A1 · Qureshi et al. · 2012 [cited by applicant]
US 20120302938A1 · Browd et al. · 2012 [cited by applicant]
US 20120330196A1 · Nita · 2012 [cited by applicant]
US 20130023814A1 · Bertrand et al. · 2013 [cited by applicant]
US 20130030411A1 · Kreck et al. · 2013 [cited by applicant]
US 20130035628A1 · Garrison et al. · 2013 [cited by applicant]
US 20130066331A1 · Chitre et al. · 2013 [cited by applicant]
US 20130085413A1 · Tsamir et al. · 2013 [cited by applicant]
US 20130126430A1 · Kenley et al. · 2013 [cited by applicant]
US 20130131811A1 · Barreiro et al. · 2013 [cited by applicant]
US 20130158470A1 · Panotopoulos · 2013 [cited by applicant]
US 20130158564A1 · Harris et al. · 2013 [cited by applicant]
US 20130165903A1 · Webler et al. · 2013 [cited by applicant]
US 20130197422A1 · Browd et al. · 2013 [cited by applicant]
US 20130248450A1 · Kenley et al. · 2013 [cited by applicant]
US 20140066830A1 · Lad et al. · 2014 [cited by applicant]
US 20140166555A1 · Dibel et al. · 2014 [cited by applicant]
US 20140194840A1 · Eckermann · 2014 [cited by applicant]
US 20140276334A1 · Eckermann · 2014 [cited by applicant]
US 20140276660A1 · Eckermann · 2014 [cited by applicant]
US 20140299546A1 · Eckert et al. · 2014 [cited by applicant]
US 20140316373A1 · Dhall · 2014 [cited by applicant]
US 20140323857A1 · Mourad et al. · 2014 [cited by applicant]
US 20140358183A1 · Saunders et al. · 2014 [cited by applicant]
US 20150094644A1 · Lenihan et al. · 2015 [cited by applicant]
US 20150129497A1 · Humes et al. · 2015 [cited by applicant]
US 20150196742A1 · Browd et al. · 2015 [cited by applicant]
US 20150223832A1 · Swaney et al. · 2015 [cited by applicant]
US 20150224284A1 · Panotopoulos et al. · 2015 [cited by applicant]
US 20150238685A1 · Elias et al. · 2015 [cited by applicant]
US 20150257774A1 · Galdonik et al. · 2015 [cited by applicant]
US 20150328295A1 · Lodge et al. · 2015 [cited by applicant]
US 20160046503A1 · Hoek et al. · 2016 [cited by applicant]
US 20160051801A1 · Vase · 2016 [cited by applicant]
US 20160101270A1 · Browd et al. · 2016 [cited by applicant]
US 20160136398A1 · Heilman et al. · 2016 [cited by applicant]
US 20160174995A1 · Turjman et al. · 2016 [cited by applicant]
US 20160303355A1 · Heilman et al. · 2016 [cited by applicant]
US 20160303356A1 · Heilman et al. · 2016 [cited by applicant]
US 20170000361A1 · Meyering et al. · 2017 [cited by applicant]
US 20170035950A1 · Meyering et al. · 2017 [cited by applicant]
US 20170035998A1 · Meyering et al. · 2017 [cited by applicant]
US 20170095649A1 · Vase et al. · 2017 [cited by applicant]
US 20170157374A1 · Hedstrom et al. · 2017 [cited by applicant]
US 20170304521A1 · McNeil · 2017 [cited by examiner]
CA 2407214A1 · 2003 [cited by applicant]
CA 2597293A1 · 2006 [cited by applicant]
CA 2793672A1 · 2011 [cited by applicant]
CA 2936349A1 · 2015 [cited by applicant]
CN 101288783A · 2008 [cited by applicant]
CN 101653637A · 2010 [cited by applicant]
CN 202409608U · 2012 [cited by applicant]
CN 102973305A · 2013 [cited by applicant]
CN 103381267A · 2013 [cited by examiner]
CN 203816046U · 2014 [cited by applicant]
CN 203935243U · 2014 [cited by applicant]
CN 105361923A · 2016 [cited by applicant]
EP 0515007B1 · 1996 [cited by applicant]
EP 1331019A2 · 2003 [cited by applicant]
EP 2086573A2 · 2009 [cited by applicant]
EP 2217315B1 · 2012 [cited by applicant]
EP 2583744A1 · 2013 [cited by applicant]
EP 2695633A1 · 2014 [cited by applicant]
EP 2882483B1 · 2016 [cited by applicant]
GB 2365344A · 2002 [cited by applicant]
JP 03504681A · 1991 [cited by applicant]
JP 2001509712A · 2001 [cited by applicant]
JP 2001513349A · 2001 [cited by applicant]
JP 2002514096A · 2002 [cited by applicant]
JP 2003515394A · 2003 [cited by applicant]
JP 2003250881A · 2003 [cited by applicant]
JP 2003526398A · 2003 [cited by applicant]
JP 2004508109A · 2004 [cited by applicant]
JP 2004236792A · 2004 [cited by applicant]
JP 2004528062A · 2004 [cited by applicant]
JP 2006514857A · 2006 [cited by applicant]
JP 2006525827A · 2006 [cited by applicant]
JP 2010505556A · 2010 [cited by applicant]
JP 2010520446A · 2010 [cited by applicant]
JP 2011526799A · 2011 [cited by applicant]
JP 2018523524A · 2018 [cited by applicant]
RU 2100965C1 · 1998 [cited by applicant]
RU 2158613C2 · 2000 [cited by applicant]
RU 2290974C1 · 2007 [cited by applicant]
RU 2312678C1 · 2007 [cited by applicant]
RU 2314838C2 · 2008 [cited by applicant]
WO 8909629A1 · 1989 [cited by applicant]
WO 9205864A1 · 1992 [cited by applicant]
WO 9802202A1 · 1998 [cited by applicant]
WO 9833535A1 · 1998 [cited by applicant]
WO 9907276A2 · 1999 [cited by applicant]
WO 0041762A1 · 2000 [cited by applicant]
WO 0043056A1 · 2000 [cited by applicant]
WO 0051669A1 · 2000 [cited by applicant]
WO 0139819A2 · 2001 [cited by applicant]
WO 0154766A1 · 2001 [cited by applicant]
WO 0211703A1 · 2002 [cited by applicant]
WO 0220083A2 · 2002 [cited by applicant]
WO 0232494A2 · 2002 [cited by applicant]
WO 02056937A2 · 2002 [cited by applicant]
WO 03015710A2 · 2003 [cited by applicant]
WO 03020208A2 · 2003 [cited by applicant]
WO 03057306A1 · 2003 [cited by applicant]
WO 2004041314A1 · 2004 [cited by applicant]
WO 2004060463A1 · 2004 [cited by applicant]
WO 2004072647A1 · 2004 [cited by applicant]
WO 2004093945A1 · 2004 [cited by applicant]
WO 2004105839A1 · 2004 [cited by applicant]
WO 2005035025A1 · 2005 [cited by applicant]
WO 2005044335A2 · 2005 [cited by applicant]
WO 2005044847A1 · 2005 [cited by applicant]
WO 2006017763A2 · 2006 [cited by applicant]
WO 2006079007A2 · 2006 [cited by applicant]
WO 2006086195A2 · 2006 [cited by applicant]
WO 2007013945A2 · 2007 [cited by applicant]
WO 2007110643A1 · 2007 [cited by applicant]
WO 2008105959A2 · 2008 [cited by applicant]
WO 2008107652A1 · 2008 [cited by applicant]
WO 2009140202A1 · 2009 [cited by applicant]
WO 2009155384A1 · 2009 [cited by applicant]
WO 2009155614A2 · 2009 [cited by applicant]
WO 2010014447A2 · 2010 [cited by applicant]
WO 2010123558A1 · 2010 [cited by applicant]
WO 2010127071A1 · 2010 [cited by applicant]
WO 2010014447A3 · 2011 [cited by applicant]
WO 2011060317A2 · 2011 [cited by applicant]
WO 2011114260A1 · 2011 [cited by applicant]
WO 2011150323A2 · 2011 [cited by applicant]
WO 2012066103A2 · 2012 [cited by applicant]
WO 2012099984A1 · 2012 [cited by applicant]
WO 2013034602A1 · 2013 [cited by applicant]
WO 2013052951A2 · 2013 [cited by applicant]
WO 2014023551A1 · 2014 [cited by applicant]
WO 2014023552A1 · 2014 [cited by applicant]
WO 2014039780A1 · 2014 [cited by applicant]
WO 2014160481A1 · 2014 [cited by applicant]
WO 2015104631A1 · 2015 [cited by applicant]
WO 2015109260A1 · 2015 [cited by applicant]
WO 2015157320A1 · 2015 [cited by applicant]
WO 2016007553A1 · 2016 [cited by applicant]
WO 2017023419A1 · 2017 [cited by applicant]
US 10,532,195 B2, 01/2020, Hedstrom et al. (withdrawn) [cited by applicant]
English Translation of Patent Publication CN-103381267-A, published Nov. 6, 2013. (Year: 2013). [cited by examiner]
Park, “Continuous Dielectrophoretic Bacterial Separation and Concentration from Physiological Media Of High Conductivity” The Royal Society of Chemistry, Lab Chip, vol. 11, pp. 2893-2900, 2011. [cited by applicant]
Japanese Rejection of Appeal for related Japanese Patent Application No. 2009-531646, mailed Jan. 25, 2016 (13 pages). [cited by applicant]
European Search Report and Opinion for European Patent Application No. 07873762.4 dated May 27, 2011 (11 pages). [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority for International Patent Application No. PCT/US2016/036626, mailed Sep. 8, 2016. [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority for International Patent Application No. PCT/US2010/01186, mailed Jun. 21, 2010 (7 pages). [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority for International Patent Application No. PCT/US2007/80834, mailed Oct. 28, 2008 (8 pages). [cited by applicant]
Arnold et al., “Electro-Rotation: Development of a Technique for Dielectric Measurements on Individual Cells and Particles.” Journal of Electrostatics, vol. 21, pp. 151-191, 1988. [cited by applicant]
Arvin et al., “The Role of Inflammation and Cytokines in Brain Injury,” Neuroscience and Biobehavorial Reviews, vol. 20, No. 3, pp. 445-452, 1996. [cited by applicant]
Banci, et al., “Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS,” PNAS, vol. 104, No. 27, pp. 11263-11267, Jul. 3, 2007. [cited by applicant]
Bayer et al., “Evaluation of the safety and immunogenicity of synthetic AB42 (AN1792) in patients with AD,” Neurology, vol. 64, pp. 94-101, Jan. 2005. [cited by applicant]
Becker et al., “Separation of Human Breast Cancer Cells from Blood by Differential Dielectric Affinity,” Proc. Natl. Acad. Sci, vol. 92, pp. 860-864, Jan. 1995. [cited by applicant]
Becker et al., “The Removal of Human Leukemia Cells for Blood Using Interdigitated Microelectrodes,” J. Phys. D: Appl. Phys; vol. 27, pp. 2659-2662, 1994. [cited by applicant]
Blennow et al., “Alzheimer's disease,” Lancet, vol. 368, pp. 387-403, Jul. 29, 2006. [cited by applicant]
Buzzigoli et al., “Plasmapherisis treatment in Guillain-Barré syndrome: potential benefit over intravenous Immunoglobin,” Anaesth Intensive Care, vol. 38, No. 2, pp. 387-389, Abstract (1 page) Mar. 2010. [cited by applicant]
Cambria et al., “Clinical Experience with Epidural Cooling for Spinal Cord Protection during Thoracic and Thoracoaabdominal Aneurysim Repair,” Journal of Vascular Surgery, vol. 25, No. 2, pp. 234-243, Feb. 1997. [cited by applicant]
Caughey et al., “Protofibrils, pores, fibrils and neurodegeneration: separating the responsible aggregates from the innocent bystanders,” Annu. Rev. Neurosci. vol. 26, pp. 267-298, 2003. [cited by applicant]
Cook, “Combined Spinal-Epidural Techniques,” Anaesthesia, vol. 55, pp. 42-64, 2000. [cited by applicant]
Covaciu et al., “Brain Temperature in Volunteers Subjected to Intranasal Cooling,” Intensive Care Med; vol. 37, No. 8, Abstract (1 page) 1277-1284, Aug. 2011. [cited by applicant]
Dawson et al., “Molecular Pathways of Neurodegeneration in Parkinson's Disease,” Science, vol. 302, pp. 819-822, Oct. 21, 2003. [cited by applicant]
Dekosky et al., “Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders,” Science, pp. 830-834, Oct. 31, 2003. [cited by applicant]
Delhaas, “Extradural and Subarachnoid Catheterization Using the Seldinger Technique,” British Journal of Anaesthesia, vol. 76, pp. 149-150, 1996. [cited by applicant]
Dias-Santagata et al., “Oxidative stress mediates tau-induced neurodegeneration in [cited by applicant]
Dunnett et al., “Prospects for new restorative and neuroprotective treatments in Parkinson's disease”, Nature, vol. 399, pp. A32-A38, SUPP, Jun. 24, 1999. [cited by applicant]
Elefteriades et al., Litigation in Nontraumatic Aortic Diseases—A Tempest in the Malpractice Maelstrom, Cardiology, vol. 109, pp. 263-272, 2008. [cited by applicant]
Enchev et al., “Historical Trends of Neuroendoscopic Surgical Techniques in the Treatment of Hydrocephalus,” Neurosurgery Review, vol. 31, pp. 249-262, 2008. [cited by applicant]
Gascoyne et al., “Dielectrophoretic Separation of Cancer Cells from Blood,” IEEE Transactions of Industry Applications, vol. 33, No. 3, pp. 670-678, May/Jun. 1997. [cited by applicant]
Gascoyne et al., “Isolation of Rare Cells from Cell Mixtures by Dielectrophoresis,” Electrophoresis, vol. 30. No. 8, pp. 1388-1398, Apr. 2009. [cited by applicant]
Gascoyne et al., “Particle Separation by Dielectrophoresis,” Electrophoresis, vol. 23, No. 13, pp. 1973-1983, Jul. 2002. [cited by applicant]
Gilman et al., “Clinical effects of Aß immunization (AN1792) in patients with AD in an interrupted trial,” Neurology, vol. 64, pp. 1553-1562, May 2005. [cited by applicant]
Glabe, “Common mechanisms of amyloid oligomer pathogenesis in degenerative disease,” Neurobiology of Aging, vol. 27, pp. 570-575, 2006. [cited by applicant]
Haltiwanger, “The Electrical Properties of Cancer Cells”, www.royalrife.com/haltiwanger1, 62 pages, Jul. 2010. [cited by applicant]
Han et al., “An Electrorotation Technique for Measuring the Dielectric Properties of Cells with Simultaneous Use of Negative Quadropolar Dielectrophoresis and Electrorotation,” The Royal Society of Chemistry, vol. 138, … [cited by applicant]
Hansson et al., “Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study,” Lancet Neurol; vol. 5, pp. 228-234, Mar. 2006. [cited by applicant]
Helmy et al., “The Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and Evidence for Cerebral Parenchymal Production,” Journal of Cerebral Blood Flow & Metabolism, vol. 31, pp. 658-670, 2011. [cited by applicant]
Hock et al., “Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease,” Neuron, vol. 38, pp. 547-554, May 22, 2003. [cited by applicant]
Hohlfeld et al., “Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines,” PNAS, vol. 101, Suppl. 2, pp. 14599-14606, Oct. 5, 2004. [cited by applicant]
Huang et al., “Electrode Design for Negative Dielectrophoresis,” Measurement Science and Technolgy, vol. 2, pp. 1142-1146, Dec. 1991. [cited by applicant]
Janus et al., “A beta peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease,” Nature, vol. 408, pp. 979-982, Dec. 2000. [cited by applicant]
Jones et al., “Multipolar Dielectrophoretic and Electrorotation Theory,” Journal of Electrostatics, vol. 37, pp. 121-134, 1996. [cited by applicant]
Kessler et al., “Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage,” Surgical Neurology, vol. 64, pp. S1:2-S1:5, 2005. [cited by applicant]
Koo et al., “Amyloid diseases: Abnormal protein aggregation in neurodegeneration,” Proc. Natl. Acad. Sci; vol. 96, pp. 9989-9990, Aug. 1999. [cited by applicant]
Kuwabara et al., “Intravenous immunoglobin therapy for Guillan-Barre syndrome with IgG anti-GM1 antibody,” Muscle & Nerve, pp. 53-58, Jan. 2001. [cited by applicant]
Lau et al., “Tau Protein Phosphorylation as a Therapeutic Target in Alzheimer's Disease,” Current Topics in Medicinal Chemistry, vol. 2, pp. 395-415, 2002. [cited by applicant]
Levi et al., “Clinical Application of Modest Hypothermia After Spinal Cord Injury,” J. Neurotrauma, vol. 26, No. 3, Abstract (1 page) pp. 407-415, Mar. 2009. [cited by applicant]
Li et al., “Continuous Dielectrophoretic Cell Separation Microfluidic Device,” The Royal Society of Chemistry, Lab Chip, vol. 7, pp. 239-248, 2007. [cited by applicant]
Macdonald et al., “Cerebral vasospasm after subarachnoid hemorrage: the emerging revolution,” Nature Clinical Practice, Neurology, vol. 3, No. 5, pp. 256-263, May 2007. [cited by applicant]
Madeira-Lopes et al., Comparative Study of the Temperature Profiles of Growth and Death of the Pathogenic Yeast Cryptococcus Neoformans and the non-pathogenic Cryptococcus Albidus,' Journal of Basic Microbiology, vol. 2… [cited by applicant]
Markx et al., “Dielectrophoretic Separation of Bacteria Using a Conductivity Gradient,” Journal of Biotechnology, vol. 51, pp. 175-180, Dec. 1996. [cited by applicant]
Markx et al., “Dielectrophoretic Separation of Cells: Continuous Separation,” Biotechnology and Bioengineering, vol. 45, No. 4, pp. 337-343, Feb. 1995. [cited by applicant]
Marszalek et al., “Determination of Electrical Parameters of Cell Membranes by a Dielectrophoresis Method,” Biophysical Journal, vol. 59, pp. 982-987, May 1991. [cited by applicant]
Mascia et al., “Temporal Relationship Between Endothelin-1 Concentrations and Cerebral Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage-Editorial Comment: Endothelin-1 in Vasospasm After SAH,” Stroke, pp. 1… [cited by applicant]
McCulloch et al., “A radical approach to stroke therapy,” PNAS, vol. 98, No. 20, pp. 10989-10991, Sep. 25, 2001. [cited by applicant]
McKeating et al., “Cytokines and Adhesion Molecules in Acute Brain Injury,” British Journal of Anaesthesia, vol. 80, pp. 77-84, 1998. [cited by applicant]
McKhann et al., “Plasmapherisis and Guillain-Barre syndrome: analysis of prognostic factors and the effect of plasmapheresis,” Annals of Neurology, vol. 23, No. 4, pp. 347-353, Apr. 1988. [cited by applicant]
Melnikova, “Therapies for Alzheimer's disease,” Nature Reviews, vol. 6, pp. 341-342, May 2007. [cited by applicant]
Misaki et al., “Contrast-Enhanced Fluid-Attenuated Inversion Recovery MRI is useful to Detect the CSF Dissemination of Glioblastoma,” Journal of Computer Assisted Tomography, vol. 25, No. 6, pp. 953-956, 2001. [cited by applicant]
Monsonego et al., “Immunotherapeutic Approaches to Alzheimer's Disease”, Science, vol. 302,pp. 834-838, Oct. 31, 2003. [cited by applicant]